www.pharmablog.nl

Weblog met nieuws over de pharmaceutische industrie

Archive for September, 2008

Aegon

Aegon
Lees meer..

  • 0 Comments
  • Filed under: 3
  • Onvoldoende begrip voor longziekten
    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Angst borstkanker stijgt meest bij jonge vrouwen
    Lees meer..

  • 0 Comments
  • Filed under: 3
  • KeyCentrix Inc. announces a partnership with national healthcare organization, PDM Healthcare.
    Lees meer..

  • 0 Comments
  • Filed under: 3
  • MedImmune Inc. has licensed its reverse genetics technology to the Research Foundation for Microbial Diseases of Osaka University in Japan (BIKEN) for use in influenza vaccine development and production.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Cephalon will pay $425 million to settle charges that it promoted three of its drugs for uses that were not approved by the Food and Drug Administration. (CEPH)

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • MedImmune Inc. has licensed its reverse genetics technology to the Research Foundation for Microbial Diseases of Osaka University in Japan (BIKEN) for use in influenza vaccine development and production.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Repros Therapeutics sells shares

    Repros Therapeutics Inc. has agreed to sell 2.4 million shares to Efficacy Capital Ltd., its largest shareholder, and an unnamed company for about $15.6 million. (RPRX)

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Memphis-based Supportive Oncology Services Inc. today launched its cancer support Web site, understandingcancer.tv, which has information that was once only available to patients at approximately 90 oncology practices.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • CPC of America Inc. has retained FTI Capital Advisors LLC to explore strategic alternatives for the company.

    Lees meer..

  • 0 Comments
  • Filed under: 3